Prosecution Insights
Last updated: October 04, 2026
Application No. 19/088,112

SURGICAL BURS

Non-Final OA §112§DOUBLEPATENT
Filed
Mar 24, 2025
Priority
Aug 31, 2015 — divisional of 10/265,082 +2 more
Examiner
GIBSON, ERIC SHANE
Art Unit
Tech Center
Assignee
Medtronic Ps Medical Inc.
OA Round
1 (Non-Final)
85%
Grant Probability
Favorable
1-2
OA Rounds
9m
Est. Remaining
99%
With Interview

Examiner Intelligence

Grants 85% — above average
85%
Career Allowance Rate
761 granted / 891 resolved
+25.4% vs TC avg
Strong +17% interview lift
Without
With
+17.2%
Interview Lift
resolved cases with interview
Typical timeline
2y 3m
Avg Prosecution
23 currently pending
Career history
908
Total Applications
across all art units

Statute-Specific Performance

§101
6.2%
-33.8% vs TC avg
§103
28.6%
-11.4% vs TC avg
§102
21.8%
-18.2% vs TC avg
§112
31.6%
-8.4% vs TC avg
Black line = Tech Center average estimate • Based on career data from 891 resolved cases

Office Action

§112 §DOUBLEPATENT
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claims 21-38 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. Claim 21 recites the limitation "the second cutting flute" in line 5. There is insufficient antecedent basis for this limitation in the claim. Claim 33 recites the limitation "the second cutting flute" in line 5. There is insufficient antecedent basis for this limitation in the claim. Double Patenting The nonstatutory double patenting rejection is based on a judicially created doctrine grounded in public policy (a policy reflected in the statute) so as to prevent the unjustified or improper timewise extension of the “right to exclude” granted by a patent and to prevent possible harassment by multiple assignees. A nonstatutory double patenting rejection is appropriate where the conflicting claims are not identical, but at least one examined application claim is not patentably distinct from the reference claim(s) because the examined application claim is either anticipated by, or would have been obvious over, the reference claim(s). See, e.g., In re Berg, 140 F.3d 1428, 46 USPQ2d 1226 (Fed. Cir. 1998); In re Goodman, 11 F.3d 1046, 29 USPQ2d 2010 (Fed. Cir. 1993); In re Longi, 759 F.2d 887, 225 USPQ 645 (Fed. Cir. 1985); In re Van Ornum, 686 F.2d 937, 214 USPQ 761 (CCPA 1982); In re Vogel, 422 F.2d 438, 164 USPQ 619 (CCPA 1970); In re Thorington, 418 F.2d 528, 163 USPQ 644 (CCPA 1969). A timely filed terminal disclaimer in compliance with 37 CFR 1.321(c) or 1.321(d) may be used to overcome an actual or provisional rejection based on nonstatutory double patenting provided the reference application or patent either is shown to be commonly owned with the examined application, or claims an invention made as a result of activities undertaken within the scope of a joint research agreement. See MPEP § 717.02 for applications subject to examination under the first inventor to file provisions of the AIA as explained in MPEP § 2159. See MPEP § 2146 et seq. for applications not subject to examination under the first inventor to file provisions of the AIA . A terminal disclaimer must be signed in compliance with 37 CFR 1.321(b). The filing of a terminal disclaimer by itself is not a complete reply to a nonstatutory double patenting (NSDP) rejection. A complete reply requires that the terminal disclaimer be accompanied by a reply requesting reconsideration of the prior Office action. Even where the NSDP rejection is provisional the reply must be complete. See MPEP § 804, subsection I.B.1. For a reply to a non-final Office action, see 37 CFR 1.111(a). For a reply to final Office action, see 37 CFR 1.113(c). A request for reconsideration while not provided for in 37 CFR 1.113(c) may be filed after final for consideration. See MPEP §§ 706.07(e) and 714.13. The USPTO Internet website contains terminal disclaimer forms which may be used. Please visit www.uspto.gov/patent/patents-forms. The actual filing date of the application in which the form is filed determines what form (e.g., PTO/SB/25, PTO/SB/26, PTO/AIA /25, or PTO/AIA /26) should be used. A web-based eTerminal Disclaimer may be filled out completely online using web-screens. An eTerminal Disclaimer that meets all requirements is auto-processed and approved immediately upon submission. For more information about eTerminal Disclaimers, refer to www.uspto.gov/patents/apply/applying-online/eterminal-disclaimer. Claims 21 and 33 are rejected on the ground of nonstatutory double patenting as being unpatentable over claim 15 of U.S. Patent No. 11,406,396 in view of Gubellini et al., U.S. PG-Pub 2012/0150209. Regarding claims 21 and 33, claim 15 of U.S. Patent No. 11,406,396 recites “A method of dissecting a tissue generally in a radial direction from a center axis of a surgical bur, the method comprising: powering a motor to rotate the surgical bur around the center axis of the surgical bur; moving the rotating surgical bur in a radial direction from the center axis toward the tissue; engaging a front wall of the tissue with a trailing edge of the surgical bur; and engaging a cutting edge of the surgical bur to the tissue after engaging the trailing edge of the surgical bur to the tissue; wherein the trailing edge and the cutting edge of the surgical bur are each a same distance from the center axis of the surgical bur to reduce vibration of the surgical bur.” Claim 15 of U.S. Patent No. 11,406,396 does not recite a body including a proximal end and a distal end, second cutting and trailing edges, first and second flutes formed between the cutting edges, first and second convex lands defined between the cutting and trailing edges, and first and second chip spaces formed between the cutting and trailing edges. Gubellini et al. discloses a surgical bur having a body that extends between a proximal end and a distal end, with first and second cutting edges (38), first and second trailing edges (edges 61 including rib crests 76), first and second flutes (46) formed between each of the cutting and trailing edges, first and second convex lands (54, 60) defined between the cutting and trailing edges, and first and second chip space (45) formed between the cutting and trailing edges (Figs. 3-5) as such increases cutting efficiency by reducing the number of rotations needed to excise a desired amount of tissue (paragraph [0051]). It would have been obvious to one having ordinary skill in the art before the effective filing date of the claimed invention to modify claim 15 of U.S. Patent No. 11,406,396 such that the surgical bur includes a body including a proximal end and a distal end, second cutting and trailing edges, first and second flutes formed between the cutting edges, first and second convex lands defined between the cutting and trailing edges, and first and second chip spaces formed between the cutting and trailing edges in view of Gubellini et al. to permit increasing cutting efficiency by reducing the number of rotations needed to excise a desired amount of tissue. Allowable Subject Matter Claims 21 and 33 would be allowable if rewritten or amended to overcome the rejection(s) under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), 2nd paragraph, set forth in this Office action and with the filing of a terminal disclaimer to overcome the non-statutory double patenting rejection set forth above. Claims 22-32 and 34-38 would be allowable if rewritten to overcome the rejection(s) under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), 2nd paragraph, set forth in this Office action and to include all of the limitations of the base claim and any intervening claims. The following is a statement of reasons for the indication of allowable subject matter: The prior art of record, alone or in combination, does not disclose a surgical bur having a body with first and second flutes, first and second cutting edges, first and second trailing edges such that the first and second cutting edges and the first and second trailing edges are spaced a first/same distance from a center axis of the surgical bur to reduce vibration during cutting as claimed. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to Eric Gibson whose telephone number is (571)270-5274. The examiner can normally be reached Monday-Thursday ~6:00 A.M. to 4:00 P.M. (CST). If attempts to reach the examiner by telephone are unsuccessful, please contact the examiner’s supervisor, Kevin Truong, at (571) 272-4705. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of an application may be obtained from the Patent Application Information Retrieval (PAIR) system. Status information for published applications may be obtained from either Private PAIR or Public PAIR. Status information for unpublished applications is available through Private PAIR only. For more information about the PAIR system, see http://pair-direct.uspto.gov. Should you have questions on access to the Private PAIR system, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative or access to the automated information system, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /ERIC S GIBSON/ Primary Examiner, Art Unit 3775
Read full office action

Prosecution Timeline

Mar 24, 2025
Application Filed
Aug 21, 2026
Non-Final Rejection mailed — §112, §DOUBLEPATENT (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12746075
System And Method For Robotically Assisting A Surgical Procedure
2y 8m to grant Granted Sep 29, 2026
Patent 12746013
MEDICAL TOOL WITH VIBRATION DAMPING
2y 10m to grant Granted Sep 29, 2026
Patent 12746014
SURGICAL RESECTION DEVICE AND METHODS OF OPERATION THEREOF
2y 8m to grant Granted Sep 29, 2026
Patent 12734038
PATCH FOR COVERING A DEFECT IN THE ANNULUS FIBROSUS OF AN INTERVERTEBRAL DISC, AND IN PARTICULAR ALSO IN THE POSTERIOR LONGITUDINAL LIGAMENT, OF A SPINE
2y 9m to grant Granted Sep 15, 2026
Patent 12728016
TOTAL ANKLE REPLACEMENT INSTRUMENTS, ASSEMBLY, AND METHODS OF USE
3y 7m to grant Granted Sep 08, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
85%
Grant Probability
99%
With Interview (+17.2%)
2y 3m (~9m remaining)
Median Time to Grant
Low
PTA Risk
Based on 891 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month